Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site
2020 · British Journal of Cancer · 85 citations
https://doi.org/10.1038/s41416-020-01153-4
A
Anne de la Rochefordière
Institut Curie(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
147
Papers
3.9K
Citations
31
h-index
47
i10-index
Anne de la Rochefordière is an academic researcher from Institut Curie. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Colorectal and Anal Carcinomas & Breast Cancer Treatment Studies. The author has an h-index of 31, co-authored 125 publications.
Papers by this author
worksGenetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer
2020 · EBioMedicine · 10 citations
https://doi.org/10.1016/j.ebiom.2020.103049
Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’
2020 · EBioMedicine · 4 citations
https://doi.org/10.1016/j.ebiom.2020.102875
Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site
2023 · British Journal of Cancer · 0 citations
https://doi.org/10.1038/s41416-023-02261-7
Data from Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.7531320
Figure S1 from Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27637665
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat